FILE - This Saturday, July 18, 2020 file photo shows a general view of AstraZeneca offices and the corporate logo in Cambridge, England. In a statement on Thursday Oct. 1, 2020, the European Medicines Agency has begun its first review process for the experimental COVID-19 vaccine being developed by Oxford University and AstraZeneca. (AP Photo/Alastair Grant, file)
{}